Bruce Campbell and Richard Carleton Take Stock of 6 Years of Public Cannabis

A special “Cannabis Week” presentation, CSE’s Anna Serin was joined by CSE CEO Richard Carleton and special guest Bruce Campbell, Founder and Portfolio Manager at StoneCastle Investment Management Inc., to recap the (brief) history of the cannabis industry in the Canadian markets, and lend their insights from the front lines of this rapidly evolving industry.

From this chat, the insights shared include Richard’s recollection of how the CSE became a key proponent of the industry some six-years(!) ago (1:19), the one-factor that triggered Bruce to lean into the once-in-a-lifetime investment opportunity presented by cannabis deregulation (7:06), and reflections on the state of the industry before the global pandemic arrived (13:56).

Listen until the end to hear Richard and Bruce’s musing on how starting a cannabis company is like buying a golf course, the impact of COVID-19 on domestic and international cannabis operators, and the growing pains that indicate that the industry still offers opportunity amidst the ongoing business and macro risks of the day.

Disclaimer: The views, information, or opinions expressed during the podcast are solely those of the individuals involved and do not necessarily represent those of the Canadian Securities Exchange and its employees.

StoneCastle Investment Management Inc. Legal Notice

Related Links
stonecastlefunds.ca

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Play / RSS

Alan Brochstein on Surviving Cannabis Industry ‘Potholes’ in Pandemic Times

CSE’s Barrington Miller is rejoined by Alan Brochstein, founder of 420 Investor and contributor to New Cannabis Ventures, to discuss the recent issues surrounding the cannabis industry, with a specific focus on what’s happening in the United States and in the stock market.

In this wide-ranging discussion, Alan shares what he thinks are the two major “potholes” on the road to U.S. legalization (3:32), the issues presented by capital constraints in a booming business segment (7:04), the benefits for those that survive the current pandemic crisis in cannabis (10:39), and the industry’s transition from stigmatization to essential service (14:13).

Listen until the end to hear Alan’s thoughts on why banking and research are the next two issues that need to be addressed (18:39), the one mistake investors in U.S. cannabis routinely make (21:14), his biggest cannabis-related disappointment during the pandemic (22:27), the best (and worst) State cannabis rollouts (23:25), why it was important for the industry to shift away from ‘vertical integration’ (30:28), and how the industry will evolve through COVID-19.

Related Links
420 Investor
New Cannabis Ventures

Disclaimer: The views, information, or opinions expressed during the podcast are solely those of the individuals involved and do not necessarily represent those of the Canadian Securities Exchange and its employees.

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Play / RSS

Chris Moreau on How Science Fiction Has Inspired a Potentially Lung-Saving Therapy

CSE’s Barrington Miller was recently joined by Christopher Moreau, CEO of Algernon Pharmaceuticals Inc. (CSE:AGN), to discuss his company’s work to develop NP-120 (Ifenprodil) as a new therapeutic in the fight against COVID-19.

In this discussion, Chris outlines how his company focuses on drug re-purposing, a term that is widely understood through the example provided by Viagra (1:04), the important distinction between therapeutic treatments and anti-virals and vaccines (12:14), and why the “grandaddy” of all market approvals is from the USFDA (18:25).

Listen until the end to hear how the company’s name is actually inspired by the title of a science fiction novel, and how the company has a history of investigating compounds developed by the Soviet Union!

(Subsequent to this chat, Algernon announced Health Canada approval to move forward with its PH2b/3 trial here with Ifenprodil as a potential treatment for COVID-19.)

Related Link
algernonpharmaceuticals.com

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Play / RSS

Andrew Nelson’s Millennial Primer on Mining Exploration Investment

CSE’s Anna Serin was recently joined by Andrew Nelson, Partner at GNA Financial Advisors Inc., to discuss the many factors involved when evaluating investment opportunities in the mining sector. This wide-ranging discussion pulls generously from Andrew’s investment banking experience in finance and capital markets and serves as a great primer for those new to investing in the space.

In this chat, Andrew describes the “lifeblood” of companies when they are raising new capital (3:17), the pillars of crafting “digestible” messaging for prospective mining sector investors (6:12), and the two key variables that can combine to create exponential value for a mining stock (14:30).

Listen until the end to hear Andrew’s very simple strategy for starting a mining portfolio, his debunking of mining industry stereotypes, and the prospects for gold investing during the COVID-19 pandemic.

Related Links:
gnafinancialadvisors.com

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Play / RSS

Hugh Rogers on the Next Opportunity in Infectious Disease Detection

CSE’s Anil Mall was recently joined by Hugh Rogers, CEO of XPhyto Therapeutics Corp. (CSE:XPHY), to discuss how the “science-first” cannabis company prioritizes its focus on formulation, clinical validation, and emerging European markets.

In this discussion, Hugh shares how the company has built a “cultivation independent” operating philosophy that sidesteps the overhead associated with large cultivators (2:29), the newest pillar to their business focused on infectious disease screening (6:00), and the advantages that the company has by sticking firmly to their “science-first” mission (14:41).

Listen until the end to hear Hugh’s insights into how he built his team through unique collaborations at the University of Alberta and the Technical University of Munich!

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Play / RSS

Terry Howlett on the Prospects of an Alternative to Alcohol-Free Hand Sanitizer

CSE’s Phillip Shum recently chatted with Terry Howlett, CEO at Ovation Science Inc. (CSE:OVAT), to discuss the company’s current developments in the midst of the COVID-19 pandemic.

In this discussion, Terry discusses his company’s alcohol-free solution to hand-sanitization (1:11), how the DermSafe product was utilized by the Canadian Olympic teams during the most recent two Games (5:20), and the geographic demand for the product in light of the pandemic (9:24).

Listen until the end to hear how their flagship product provides 4-hour protection against germs and how it may be a key tool as society reopens in the coming months.

Subscribe:  Apple Podcasts / Spotify / SoundCloud / Stitcher / Google Play / RSS

Reg A+: Dancing Through a US Capital Raise | CSE Webinar

Kenneth Sam, Partner of Capital Markets at Dorsey & Whitney LLP, joined the CSE in this fourth instalment of our educational conference series, “All Locked Down and No Place to Go.” In this highly insightful webinar, Sam uses his background as a cross-border securities lawyer in Canada and the US to lead the conversation on Regulation A+, also known as Reg A+.

In this comprehensive presentation, Sam discusses the importance of Reg A+ to the global economy and global markets (3:15), the eligibility of issuers for using Reg A+ (10:30), and the advantages of the regulation (12:40). He also talks about how Reg A+ can apply to the CSE, including the reasons CSE-listed companies would look to use this offering (35:34) and how Reg A+ can help US companies that want to go public on the CSE (37:27).

Watch until the end to hear Sam’s valuable answers to the thought-provoking questions from the conference participants, including a question on the reduction and regulatory burden of Reg A+ compared to the normal systems. As well, Sam provides additional resources on the subject.

A Primer on At-the-Market (ATM) Offerings | CSE Webinar

When: Tuesday, April 28th at 1:15PM PDT / 4:15PM EDT
Where: Zoom Video Conference
How: RSVP to media@thecse.com 

The CSE looks forward to hosting “A Primer on At-the-Market (ATM) Offerings” on Tuesday, April 28th, 2020.

Part of the CSE’s “All Locked Down and Nowhere to Go” educational conference series, next Tuesday’s webinar will centre on ‘at-the-market’ (ATM) offerings – a financing strategy that is becoming progressively utilized in Canadian public markets as it provides the ability to lower a company’s cost of capital relative to other financing options.

We are pleased to welcome Ron Sedran, Managing Director, Equity Capital Markets from Canaccord Genuity, and Chad Schneider, Partner at Blakes, to highlight the advantages of this funding mechanism and to share their own professional advice on when, and how, to facilitate an ATM offering.

To participate in this insightful discussion, please RSVP by sending an email to media@thecse.com.

Robyn Rabinovich on the Cannabis Sector’s Adjustment to Quarantine Life

CSE’s Grace Pedota recently chatted with Robyn Rabinovich, Senior Account Director, Cannabis at Hill+Knowlton Strategies, to reflect on her professional experiences in the rapidly evolving cannabis industry, dating back to the onset of the MMPR program in Canada.

In this comprehensive discussion, Robyn shares her favourite aspects of working at start-ups like CannTrust and TerrAscend (3:34), how Hill+Knowlton has uniquely positioned itself to provide B2B support to the industry (4:48), defining Cannabis 2.0 and what to expect from the 3.0 era (6:09), and her perspective on the Ontario cannabis retail situation amid COVID-19 shutdowns (11:54).

Listen until the end to hear her thoughts on how new technological applications are benefiting the cannabis industry, the prospects for consumption lounges in Toronto, and the new favourite quarantine pastime for those in the cannabis industry (hint: it’s not product consumption!)

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Play / RSS

Howie Mandel on Charity, Commerce and Comedy in 2020

On this very special edition of #HashtagFinance, CSE’s Anil Mall and James Black are joined by legendary comedian – and entrepreneur – Howie Mandel, to discuss how he is coping with quarantine life, his charitable collaboration with Trevor Doerksen and ePlay Digital (CSE:EPY) and much (much) more.

In this conversation, Howie shares how his reputation as a germaphobe dovetailed into the game “Outbreak”, which evolved into a charitable tool to outfit PPE to frontline health-care workers (7:05), how technology can be a catalyst for powering the next generation of small business (and comedy) (11:24), and his simple – yet powerful – views on investing in the stock market (24:38).

Listen until the end to hear Howie’s big vision for Just for Laughs (he owns a partnership stake), how he embraces technological innovation, and his encouragement for everyone to stop overthinking and “Just Do It”.

Related Links:
www.howiesgames.com
talkshop.live
www.eplaydigital.com

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Play / RSS